COPD Foundation to Host Patient-Focused Drug Development Meeting
The COPD Foundation announced an upcoming meeting to ensure patient experiences and priorities are incorporated into the future of therapeutic development.
The COPD Foundation announced an upcoming meeting to ensure patient experiences and priorities are incorporated into the future of therapeutic development.
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
Results from the HOPE-3 trial found that an investigational cell therapy called deramiocel preserved heart and muscle function in boys and young men with Duchenne muscular dystrophy (DMD).
The American College of Allergy, Asthma, and Immunology (ACAAI) outlines essential steps for families and school staff to navigate seasonal allergy triggers and respiratory health.